Recent clinical research suggests that semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, may help reduce liver fat accumulation and improve liver function markers
For some of our patientsespecially those experiencing significant symptoms like fatigue, weakness, or numbnesspositive changes such as increased energy or improved mood can begin as early as 24 to 72 hours after the first injection
The Ripple Effects of GLP-1 Use GLP-1 use is reshaping daily life in ways that extend far beyond individual health outcomes and into family dynamics, community behaviors, and even broader cultural norms and ideals
Metformin is used in combination with diet and exercise
Management & Board of Directors Pratap Sandhu Chief Executive Officer A visionary entrepreneur with deep roots in food manufacturing, Pratap transformed his familys business from a small operation to a global success
Chronic fatigue syndrome is a cumbersome illness to experience, and so it must be managed